Procollagen-i and collagen-i in the serum and dialysate of CAPD patients: changes over time
Digenis, G.E.; Dombros, N.V.; Balaskas, E.V.; Christophoraki, M.; Kontessis, P.; Papantoniou, V.; Zerefos, N.; Tourkantonis, A.
Peritoneal Dialysis International Journal of the International Society for Peritoneal Dialysis 15(8): 371-374
1995
ISSN/ISBN: 0896-8608 PMID: 8785239 Document Number: 444290
Document emailed within 1 workday
Related Documents
Siemińska, A. 1996: N-terminal peptide of type III procollagen in serum and bronchoalveolar fluid as a marker of collagen metabolism in chronic interstitial lung diseases Przeglad Lekarski 53(7): 574-578Lin, J.S.; Kao, J.T.; Tsai, K.S. 1996: Type I collagen and procollagen fragments in patients with metabolic bone diseases Journal of the Formosan Medical Association 95(7): 523-529
Merritt, S.E.; Killen, P.D.; Phan, S.H.; Wiggins, R.C. 1990: Analysis of alpha 1 (I) procollagen alpha 1 (IV) collagen, and beta-actin mRNA in glomerulus and cortex of rabbits with experimental anti-glomerular basement membrane disease. Evidence for early extraglomerular collagen biosynthesis Laboratory Investigation; a Journal of Technical Methods and Pathology 63(6): 762-769
Sakao, Y.; Kato, A.; Sugiura, T.; Fujikura, T.; Misaki, T.; Tsuji, T.; Sakakima, M.; Yasuda, H.; Fujigaki, Y.; Hishida, A. 2008: Cloudy dialysate and pseudomembranous colitis in a patient on CAPD Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 28(5): 562-563
Bro, S.; Brandi, L.; Daugaard, H.; Olgaard, K. 1997: Calcium concentration in the CAPD dialysate: what is optimal and is there a need to individualize? Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 17(6): 554-559
Snitkoff, G.; Bailie, G.R.; Eisele, G. 1995: Interleukin, endotoxin, and tumor necrosis factor in CAPD dialysate Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 15(6): 279-280
Van, V.; Schoonjans, R.S.; Struijk, D.G.; Verbanck, J.J.; Vanholder, R.C.; Van, B.; Lefebvre, R.A.; De, V.; Lameire, N.H. 2002: Influence of dialysate on gastric emptying time in peritoneal dialysis patients Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 22(1): 32-38
Tanigawa, S.; Kinoshita, Y.; Kurosu, H.; Mogi, M.; Masutani, M.; Hayashi, H.; Okayasu, M. 1987: Significance of serum type IIi procollagen N-terminal peptide in patients with fibrotic lung disease Nihon Kyobu Shikkan Gakkai Zasshi 25(11): 1194-1201
Kárteszi, M.; Szalay, L.; Cornides, A.; Dávid, K.; Fehér, J. 1988: Determination of the aminoterminal peptide of procollagen type III and laminin P1 in serum of patients with chronic liver disease Acta Medica Hungarica 45(3-4): 277-286
Akman, S.; van Westrhenen, R.; De Waart, D.R.; Hiralall, J.K.; Zweers, M.M.; Krediet, R.T. 2003: The effect of dwell time on dialysate cancer antigen 125 appearance rates in patients on continuous ambulatory peritoneal dialysis Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis 19: 24-27
Schnabel, R.; Jaszovszky, S.; Bokor, M.; Garam, T. 1991: Serum aminoterminal type III procollagen peptide level and killer cell activity in patients with alcoholic liver diseases Orvosi Hetilap 132(27): 1479-1483
Zissimopoulos, A.; Bantis, A.; Stellos, K.; Petrakis, G.; Matthaios, D. 2008: Association between bone scintigraphy and serum levels of procollagen (I) and PSA in the detection of bone disease in prostate cancer patients Journal of BUON: Official Journal of the Balkan Union of Oncology 13(1): 69-74
Oppermann, F.; Fassbinder, W.; Klempa, I.; Frunkfurt; Heidelberg 1976: Effects of calcium-concentration changes in the dialysate and serum on serum gastrin level during hemodialysis Zeitschrift für Gastroenterologie 14 Suppl: 230-231
Misaki, M.; Shima, T.; Yano, Y.; Sumita, Y.; Kano, U.; Murata, T.; Watanabe, S.; Suzuki, S. 1990: Basement membrane-related and type IIi procollagen-related antigens in serum of patients with chronic viral liver disease Clinical Chemistry 36(3): 522-524
Bjermer, L.; Thunell, M.; Hällgren, R. 1986: Procollagen III peptide in bronchoalveolar lavage fluid. A potential marker of altered collagen synthesis reflecting pulmonary disease in sarcoidosis Laboratory Investigation; a Journal of Technical Methods and Pathology 55(6): 654-656
Kim, K.J.; Yang, W.S.; Kim, S.B.; Lee, S.K.; Park, J.S. 1997: Fibrinogen and fibrinolytic activity in CAPD patients with atherosclerosis and its correlation with serum albumin Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 17(2): 157-161
Pierce, G.F.; Brown, D.; Mustoe, T.A. 1991: Quantitative analysis of inflammatory cell influx, procollagen type i synthesis, and collagen cross-linking in incisional wounds: influence of PDGF-BB and TGF-beta 1 therapy Journal of Laboratory and Clinical Medicine 117(5): 373-382
Lukinmaa, P.L. 1988: Immunofluorescent localization of type IIi collagen and the N-terminal propeptide of type IIi procollagen in dentin matrix in osteogenesis imperfecta Journal of Craniofacial Genetics and Developmental Biology 8(3): 235-243
Kang, S.W.; Lee, S.W.; Lee, I.H.; Kim, B.S.; Choi, K.H.; Lee, H.Y.; Han, D.S. 1997: Impact of metabolic acidosis on serum albumin and other nutritional parameters in long-term CAPD patients Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis 13: 249-252
Höckerstedt, K.; Risteli, L.; Salmela, K.; Risteli, J. 1990: Serum type IIi procollagen as a marker in liver transplantation Transplantation Proceedings 22(4): 1574-1575